OMAR ON: Open Payments
NPI 1295889871 · CHICO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,295 in 128 payments from 18 companies in 2025. Trend: 2023 $17,722 · 2024 $16,730 · 2025 $2,295
Food & beverage: $2,096Education: $199
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 14 | $340 |
| ABBVIE INC. | 26 | $325 |
| Janssen Biotech, Inc. | 14 | $256 |
| Amgen Inc. | 13 | $214 |
| Organon LLC | 12 | $212 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 10 | $156 |
| GENZYME CORPORATION | 8 | $142 |
| SANOFI-AVENTIS U.S. LLC | 1 | $99 |
| Arcutis Biotherapeutics, Inc. | 6 | $97 |
| E.R. Squibb & Sons, L.L.C. | 4 | $87 |
Products named: Bimzelx, DUPIXENT, TREMFYA, SKYRIZI, Otezla, Winlevi, Zoryve, VTAMA.
Industry payments across CA — which companies pay providers there.
